Clinical Trial Update: Phase II Study Evaluating the Efficacy of Tacrolimus Extended Release Tablets to Twice Daily Tacrolimus Dosing Regimen [Phase 2]

View source ↗

Summary

Phase II study evaluating whether tacrolimus extended-release tablets are as effective as standard twice-daily tacrolimus dosing in heart transplant rejection a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft Failure
• Heart Transplant Rejection

Drugs mentioned

• Tacrolimus Extended Release Tablet (Tacrolimus)

Snippet

Sponsor: Baylor Research Institute | Conditions: Heart Transplant Rejection, Graft Failure | Phase 2 | Status: COMPLETED